30 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Mycobacterium tuberculosis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Mycobacterium tuberculosis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
COVID-19 review…here is a list of some of the drugs that are currently being used or
most effective treatments ... #CoronaVirus #Treatment ... #Management #Pandemic ... Pharmacotherapy #Pharmacology ... #CriticalCare #
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis #IDSA ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... multidrug-resistant tuberculosis ... #MDRTB #management ... #pharmacology # ... ebm #idsa
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology